Ενδεικτικές Δημοσιεύσεις σε επιστημονικά περιοδικά
(Επιλογή από άνω των εκατό δημοσιεύσεων σε περιοδικά διεθνούς κύρους)
• Emmanouilides C: Πρόταση Οργάνωσης Ογκολογικής Περίθαλψης (Reorganization of Oncologic Care in Greece) Arch Hellen Med, 33(4), July-August 2016, 542-549
• Εmmanouilides C, Karampola M, Beredima M: Biosimilars, hope and concern: J Oncol Pharm Pract. 2016 Aug;22(4):618-24
• Makris G, Kantzioura A, Beredima M, Karampola M, Emmanouilides C. Feasibility of rapid infusion of bevacizumab in patients with cancer. J BUON. 2015 May-Jun;20(3):923-7.
• Emmanouilides C, Tryfon S, Baka S, Titopoulos H, Dager A, Filippou D. Operation for preservation of lung parenchyma in patients with lung cancer: Ex vivo and in situ reimplantation techniques. Anticancer Res. 2015 Mar;35(3):1675-81
• Levy R, Ganjoo KN, Leonard JP, Vose JM, Flinn IW, Ambinder RF, Connors JM, Berinstein NL, Belch AR, Bartlett NL, Nichols C, Emmanouilides CE, et al: Active idiotype vaccination in patients with cancer: American J of Oncology. 2014 Jun 10;32(17):1797-803.

• Emmanouilides C, Chourmouzi D, Dedes I, Pantoleon D, Mantziari P, Drevelengas A. : Successful management of osseous metastasis from renal cell carcinoma with arterial embolization and radiofrequency ablation. Cases J. 2009 Jun 29;2:6484..

• Emmanouilides C, Sfakiotaki G, Androulakis N, et al: Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study. BMC Cancer. 2007 May 30;7:91.

• Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C.. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004 Dec 16;351(25):2590-8.